Authored Items
The Evolving Role of Outcomes and End Points in Evaluating Therapy for Hematologic Malignancies: Value-Driven Benefit Design and Utilization Management Strategies
Gary C. Yee, PharmD, FCCP, BCOP, James T. Kenney Jr, RPh, MBA, Michael Mauro, MD
Supplements
ASH Highlights on Non-Hodgkin Lymphoma: A Payer's and Pharmacist's Perspective
Dwight D. Kloth, PharmD, FCCP, BCOP, Gary C. Yee, PharmD, FCCP, BCOP
Supplements
Cutaneous and Peripheral T-Cell Lymphomas: The Latest in Treatment Advances and Management Strategies
Gary C. Yee, PharmD, FCCP, BCOP, Robin Gemmill, RN, MSN, CNS, CWOCN
Supplements
Current and Future Perspectives on the Treatment of Cutaneous T-cell Lymphoma and Peripheral T-cell Lymphoma
Sue McCann, RN, BSN, DCN, Gary C. Yee, PharmD, FCCP, BCOP
Supplements
Last modified: February 23, 2011